CORONAVIRUS NEWS
Detection of circulating SARS-CoV-2 neutralising antibodies
The SARS-CoV-2 pandemic is one of the most urgent infectious disease challenges the world has faced in recent history. As few treatment options exist, the need to evaluate neutralising antibodies to fight the virus is at an all-time high.- Coronavirus
New SARS-CoV-2 test provides results in 39 minutes
A rapid new coronavirus test, which provides results in just 39 minutes, is now available on the Vivalytic, a point-of-care platform brought to market by Randox Laboratories and Bosch.- Coronavirus
Successful evaluation of PrimeStore MTM viral transport medium
EKF Diagnostics has announced that the viral transport medium PrimeStore MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England.- Coronavirus
Dundee biomedical scientist wins award for writing on PV testing
A Dundee-based biomedical scientist has won the 2020 Bernie Benson Prize for his science writing. The competition sought to promote the understanding and exploration of blood viscosity testing.- Coronavirus
Contact tracing app security flaws
The CEO of a British technology company has warned the government of potential serious flaws in the security of personal information and data used in the new contact tracing app technology that was announced by Matt Hancock.- Coronavirus
New RNase Inhibitor ensures reliable RNA protection
PCR Biosystems has launched RiboShield RNase Inhibitor, a robust and reliable RNase inhibitor that is now available as a standalone product.- Coronavirus
Global COVID-19 long-term study launched
Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19, and are inviting hospitals and healthcare sites worldwide to join this new initiative.- Coronavirus
SARS-CoV-2 ELISA laboratory test launched
Avacta Group, the developer of Affimer biotherapeutics and reagents, has announced its intention to launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.- Coronavirus
Viral transport media production scaled up in response to SARS-CoV-2
Teknova, a manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has responded to the SARS-CoV-2 pandemic by significantly scaling up production of Viral Transport Medium (VTM) and saline.- Coronavirus
Rapid SARS-CoV-2 antigen test manufacturing capacity expanded
Avacta Group, the developer of Affimer biotherapeutics and reagents, has entered an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test as part of an ongoing expansion of manufacturing capacity.- Coronavirus
Expanded SARS-CoV-2 testing with electrochemiluminescence immunoassay
Avero Diagnostics, a physician-owned US laboratory, has announced the expansion of its COVID-19 testing portfolio with the addition of the Roche Elecsys anti-SARS-CoV-2 antibody test.- Coronavirus
Deployment of novel, cost-effective SARS-CoV-2 vaccine technology
Edinburgh-based biotechnology company Ingenza has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current pandemic and COVID-19 disease.- Coronavirus
Reducing viral replication by aryl hydrocarbon receptor inhibition
Hercules Pharmaceuticals has announced the publication of promising preclinical in vivo trial results showing efficacy of its aryl hydrocarbon receptor (AhR) inhibitor HP163 against Zika virus infection and potentially against coronavirus.- Coronavirus
Executive War College: ongoing virtual interactive sessions
Remarkable things are happening as laboratories and anatomical pathology groups answer the challenges of the SARS-CoV-2 pandemic and the need for greater numbers of virus tests. Despite shortages, laboratories are adding SARS-CoV-2 test capacity.- Coronavirus
Molecular transport medium optimised for molecular testing
PrimeStore MTM is a molecular transport medium that provides a ‘snapshot’ in time of a sample by preserving and stabilising DNA and RNA. This means that samples can be collected, transported, and processed safely and efficiently.- Coronavirus
Antibodies for SARS-CoV-2 virus detection
ViroStat has released a set of new monoclonal antibodies to the nucleocapsid of the SARS-CoV-2 virus. These five antibodies were selected from a group of 60 based on highest binding affinity and best ELISA pairing to detect native viral antigen.- Coronavirus
Winter multiplex virus detection kit
Pro-Lab Diagnostics has announced that final-stage clinical trials are underway on the VIASURE Winter Multiplex CFR kit, which is expected to achieve CE certification by the end of August. Preliminary data show excellent performance characteristics.- Coronavirus
Clinical validation of Adeptrix COVID-19 diagnostic test
Avacta Group, the developer of Affimer biotherapeutics and reagents, has begun work with the UK government’s CONDOR programme to evaluate and validate the high-throughput COVID-19 bead-assisted mass spectrometry (BAMS) assay developed with Adeptrix.- Coronavirus
Molecular transport medium for dual SARS-CoV-2 and influenza sampling
EKF Diagnostics has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range. PrimeStore MTM is a collection device that deactivates viruses.- Coronavirus
Production of Platelia SARS-CoV-2 Total Ab test accelerated
Bio-Rad Laboratories is accelerating production of its Platelia SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.- Coronavirus
Featured Supplier
The British In Vitro Diagnostics Association represents the IVD Industry in the UK, to Government, professional bodies, the public, and at MedTech Europe. Giving support to members on regulatory issues, BIVDA also promotes the clinical and cost utility of IVDs in the provision of effective healthcare, both in acute diagnosis and in the prediction...
